YSB Inc. (HKG:9885)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.060
+0.010 (0.33%)
Jun 18, 2026, 4:08 PM HKT
Market Cap2.09B -66.4%
Revenue (ttm)23.34B +17.1%
Net Income170.22M +409.7%
EPS0.24 +378.3%
Shares Out 682.25M
PE Ratio12.50
Forward PEn/a
Dividend0.13 (4.17%)
Ex-Dividend DateMay 26, 2026
Volume2,348,000
Open3.070
Previous Close3.050
Day's Range3.030 - 3.150
52-Week Range2.960 - 12.660
Beta0.52
AnalystsStrong Buy
Price Target10.52 (+243.79%)
Earnings DateMar 23, 2026

About YSB Inc.

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist... [Read more]

Sector Healthcare
Founded 2015
Employees 6,950
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9885
Full Company Profile

Financial Performance

In 2025, YSB Inc.'s revenue was 20.97 billion, an increase of 17.13% compared to the previous year's 17.90 billion. Earnings were 152.97 million, an increase of 409.66%.

Financial numbers in CNY Financial Statements